In a randomized double-blind placebo-controlled trial when compared liraglutide to placebo, time to onset of diabetes was 2.7 times longer in liraglutide group. Thus liraglutide might reduce the risk of diabetes in patients with obesity and pre-diabetes.
In your opinion, how helpful liraglutide would be in clinical practice for diabetes?